The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results